Mohammad-Ehsan Owrangi
Endocrinology, Diabetes & Metabolism · Montgomery, ALNPI 1023660677
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,944, more than ten times the $118 reported in 2023. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in AL, where the typical reported total is $6,650.
Across 144 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Radius Health, Inc.$300
- Bayer$297
- Novo Nordisk$285
- Amneal Pharmaceuticals LLC$217
- BETA Bionics, Inc.$179
- Medtronic$166
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Radius Health, Inc. | 10 | $300 |
| Bayer | 37 | $297 |
| Novo Nordisk | 13 | $285 |
| Amneal Pharmaceuticals LLC | 17 | $217 |
| BETA Bionics, Inc. | 7 | $179 |
| Medtronic | 3 | $166 |
| Lilly USA, LLC | 9 | $165 |
| Xeris Pharmaceuticals, Inc. | 7 | $157 |
| Dexcom, Inc. | 5 | $100 |
| Amgen | 4 | $95 |
| Recordati_rare_diseases_inc. | 4 | $76 |
| Mannkind Corporation | 2 | $74 |
| Corcept Therapeutics | 4 | $70 |
| IBSA Pharma Inc. | 3 | $68 |
| Abbott | 3 | $61 |
| Tandem Diabetes Care, Inc. | 2 | $60 |
| Boehringer Ingelheim | 3 | $52 |
| AbbVie | 3 | $45 |
| RGH Enterprises LLC | 2 | $43 |
| Novartis | 2 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
| Chiesi USA, Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
How this compares
$2,619 in reported general payments places this provider in the 30th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.
See all endocrinology, diabetes & metabolism providers in Alabama →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 68 | $72,923 |
| MounjaroTirzepatide | 38 | $42,875 |
| JardianceEmpagliflozin | 38 | $34,880 |
| TrulicityDulaglutide | 16 | $19,326 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 15 | $12,728 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $9,860 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $7,629 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 40 | $5,228 |
| Novolog FlexpenInsulin Aspart | 15 | $3,905 |
| Humalog Kwikpen U-100Insulin Lispro | 15 | $3,387 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 38 | $3,372 |
| SynthroidLevothyroxine Sodium | 18 | $1,560 |
| Hydrocortisone | 16 | $1,192 |
| Levothyroxine Sodium | 76 | $729 |
| Metformin Hcl ErMetformin Hcl | 35 | $436 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $285 | $72,92368 claims |
| Lilly USA, LLCMounjaro, Trulicity | $165 | $62,20254 claims |
| Boehringer IngelheimJardiance | $52 | $34,88038 claims |
| AbbVieSynthroid | $45 | $1,56018 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $217 | $72976 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.
Other endocrinology, diabetes & metabolism in Montgomery
- Hima AmmanaMontgomery$9K
- Manisha GargMontgomery$8K
- Warda NiazMontgomery$8K
- Vaishall ThudiMontgomery$8K
- Elaina AdderleyMontgomery$7K
- Ahsan FarooqMontgomery$4K
- Neil SchaffnerOpelika$642K
- Ralph TeagueBirmingham$487K
- Bantwal BaligaOpelika$483K
- William GarveyBirmingham$421K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.